Mechera, Robert
Soysal, Savas D.
Piscuoglio, Salvatore
Ng, Charlotte K. Y.
Zeindler, Jasmin
Mujagic, Edin
Däster, Silvio
Glauser, Philippe
Hoffmann, Henry
Kilic, Ergin
Droeser, Raoul A.
Weber, Walter P.
Muenst, Simone
Funding for this research was provided by:
Holcim Foundation for the Advancement of Scientific Research
Claudia von Schilling Foundation for Breast Cancer Research
Freiwillige Akademische Gesellschaft Basel
Dr. Arnold U. und Susanne Huggenberger-Bischoff Stiftung zur Krebsforschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PZ00P3_168165)
Article History
Received: 5 June 2018
Accepted: 28 December 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: Ethical standards and patients’ confidentiality were ensured and in line with regulations of the local institutional review board and data safety laws. The study proposal was submitted to and approved by the ethics committee of northern and central Switzerland (Ethikkomission Nordwest- und Zentralschweiz, (EKNZ), Nr. 2014–397). The EKNZ waived the need for patient consent to participate in this study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.